Literature DB >> 13106225

Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea-pigs and mice.

M BARNETT, S R BUSBY, D A MITCHISON.   

Abstract

Entities:  

Keywords:  MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID ISOMERS/effects

Mesh:

Substances:

Year:  1953        PMID: 13106225      PMCID: PMC2073524     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


× No keyword cloud information.
  4 in total

1.  The bactericidal action of isoniazid, streptomycin and terramycin on extracellular and intracellular tubercle bacilli.

Authors:  G B MACKANESS; N SMITH
Journal:  Am Rev Tuberc       Date:  1953-03

2.  Comparison of techniques for measuring the isoniazid resistance of tubercle bacilli.

Authors:  D A MITCHISON
Journal:  J Clin Pathol       Date:  1953-05       Impact factor: 3.411

3.  Isoniazid-resistant strains of tubercle bacili; their development and stability.

Authors:  M BARNETT; S R M BUSHBY; D A MITCHISON
Journal:  Lancet       Date:  1953-02-14       Impact factor: 79.321

4.  The enumeration of viable tubercle bacilli by surface plate counts.

Authors:  F FENNER
Journal:  Am Rev Tuberc       Date:  1951-10
  4 in total
  14 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.

Authors:  W FOX; I SUTHERLAND
Journal:  Thorax       Date:  1955-06       Impact factor: 9.139

3.  Observations on the effect of isoniazid and streptomycin on tubercles in a transparent chamber in the rabbit's ear.

Authors:  L F DODSON; A G SANDERS; H W FLOREY
Journal:  Br J Exp Pathol       Date:  1955-06

4.  Outbreak of isoniazid resistant tuberculosis in north London.

Authors:  M C Ruddy; A P Davies; M D Yates; S Yates; S Balasegaram; Y Drabu; B Patel; S Lozewicz; S Sen; M Bahl; E James; M Lipman; G Duckworth; J M Watson; M Piper; F A Drobniewski; H Maguire
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

5.  The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.

Authors:  C V RAMAKRISHNAN; A L BHATIA; S DEVADATTA; W FOX; A S NARAYANA; J B SELKON; S VELU
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

6.  Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control Study.

Authors:  Phillip P Salvatore; Mercedes C Becerra; Pia Abel zur Wiesch; Trevor Hinkley; Devinder Kaur; Alexander Sloutsky; Ted Cohen
Journal:  J Infect Dis       Date:  2015-06-19       Impact factor: 5.226

7.  Antimicrobial therapy of pulmonary tuberculosis.

Authors:  W McDermott
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

Review 8.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Borna Müller; Sonia Borrell; Graham Rose; Sebastien Gagneux
Journal:  Trends Genet       Date:  2012-12-13       Impact factor: 11.639

9.  Attack rate of tuberculosis in a 5-year period among close family contacts of tuberculous patients under domiciliary treatment with isoniazid plus PAS or isoniazid alone.

Authors:  S Devadatta; J J Dawson; W Fox; B Janardhanam; S Radhakrishna; C V Ramakrishnan; S Velu
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

10.  A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India.

Authors: 
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.